resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update

NEXT STORY
Apellis Pharmaceuticals Reports Third Quarter 2019 Business Update and Financial Results
PREV STORY
Allogene Therapeutics and Notch Therapeutics Announce Collaboration to Research and Develop Induced Pluripotent Stem Cell (iPSC)-Derived Allogeneic Therapies for Hematologic Cancer Indications
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019

author_avatar
NASDAQ Market News

Burning Rock to be Added to MSCI China Index

author_avatar
NASDAQ Market News